Nuvation Bio Inc. Class A Common Stock (NUVB)
2.8900
0.00 (0.00%)
Nuvation Bio Inc is a biotechnology company focused on the development of innovative therapies to treat cancer and other serious diseases
By leveraging advanced scientific expertise and cutting-edge technologies, Nuvation Bio aims to create novel drug candidates that address unmet medical needs. The company's efforts center around its commitment to precision medicine, and it conducts extensive research to understand the underlying mechanisms of diseases, which informs the design of targeted treatment options. Through collaboration with partners in the biopharmaceutical industry, Nuvation Bio seeks to bring transformative therapies to patients while pushing the boundaries of scientific knowledge in the field of oncology.
Frequently Asked Questions
Is Nuvation Bio Inc. Class A Common Stock publicly traded?
Yes, Nuvation Bio Inc. Class A Common Stock is publicly traded.
What exchange does Nuvation Bio Inc. Class A Common Stock trade on?
Nuvation Bio Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Nuvation Bio Inc. Class A Common Stock?
The ticker symbol for Nuvation Bio Inc. Class A Common Stock is NUVB on the New York Stock Exchange
What is the current price of Nuvation Bio Inc. Class A Common Stock?
The current price of Nuvation Bio Inc. Class A Common Stock is 2.890
When was Nuvation Bio Inc. Class A Common Stock last traded?
The last trade of Nuvation Bio Inc. Class A Common Stock was at 7:00 pm EST on January 3rd, 2025